2025
The final training phase through an innovative e-learning platform involving more than 1,000 healthcare workers from Spain, Italy and Greece has just been launched after a successful pilot phase in terms of users’ engagement and satisfaction.
2025
16 January, 2025 — The pioneering project READI — Research in Europe and Diversity Inclusion — a public-private partnership funded by the Horizon Europe Innovative Health Initiative (IHI) and driven by meaningful co-leadership with patients,
2025
A significant milestone has been reached in the fight against paediatric HIV with the enrolment of the first participants in the UNIVERSAL1 trial. This achievement is a testament to the tremendous effort and dedication of the site staff in Uganda and Zimbabwe.
2024
Antimicrobial resistance (AMR), as defined by the WHO, occurs when bacteria, viruses, fungi, and parasites no longer respond to medications. This is a growing global health crisis because AMR makes infections harder to treat and increases the risk of disease spread,
2024
On 16th September, 2024 we kicked off the second edition of our online course, “Fungal Infections in Paediatrics” on our PentaTr@ining platform,
2024
In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.
2024
Laurus Labs has submitted an application to the US Food and Drug Administration (FDA) for the tentative approval of paediatric Darunavir/ritonavir (pDRV/r (120/20 mg)). UNIVERSAL is the first product development project from the World Health Organisation’s (WHO) GAP-F project which was established to promote the development of safer,
2024
This World Hepatitis Day, with the theme “It’s Time for Action,” let’s turn our focus to underserved and often overlooked populations in the fight against this preventable disease, children and pregnant people.
2024
The PediCAP trial team is pleased to announce the successful completion of a series of dissemination meetings aimed at sharing trial results with key stakeholders in Mozambique. These meetings targeted a diverse audience,
2024
The PediCAP consortium, a global partnership of 14 institutions, presented promising results from its main trial, PediCAP-A, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) conference held from April 27-30,
2024
This World Immunisation Week, Penta – Child Health Research proudly recognises 50 years of progress in child immunisation and the power of vaccines in protecting preventable diseases. Vaccination programs worldwide have saved millions of children’s lives and continue to be a powerful tool for promoting global health equity.
2023
In recent years, advancements in medical research have paved the way for an array of treatment options for children living with HIV. The efforts of scientists and researchers globally, have led to continuous refinement and improvement of existing regimens.
2023
Findings from the Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (PENTA-17) trial, simply known as SMILE, were published in eClinicalMedicine on 2 June 2023.
2022
2022
On 12 May, a Rapid Communication on the reported increase of acute hepatitis of unknown origin in children was published in Eurosurveillance. The paper outlines the extent and geographical distribution of these unexplained paediatric hepatitis cases in Europe and beyond.
2021
Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants
The University of Padua and Penta Foundation are leaders of VERDI,
2021
It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives that are lost daily to chest infections (pneumonia).
2021
It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf of the ODYSSEY trial team!